资讯
10月
News-Medical.Net on MSNCannabidiol shows promise in treating cognitive disordersBy Dr. Sanchari Sinha Dutta, Ph.D. Uncover how this plant-derived compound could revolutionize cognitive health, offering new ...
Cannabidiol is a component of marijuana that does not activate cannabinoid receptors, but moderately inhibits the degradation of the endocannabinoid anandamide. We previously reported that an ...
Around 5% of healthy adults exposed to cannabidiol show elevated liver enzyme levels exceeding the normal threshold alongside ...
Cannabidiol within the range consumers are taking with unregulated products linked to increase in liver enzymes.
Adolescent vaping of delta-9-tetrahydrocannabinol, cannabidiol, and synthetic cannabinoids increased significantly from 2021 to 2023.
CBD (cannabidiol) is a non-psychoactive compound found in cannabis, used for its potential health benefits, including pain relief, reducing anxiety, and anti-inflammatory effects.
Cannabidiol Market Growth. Key Takeaway. Market Growth: The global cannabidiol (CBD) market reached USD 7.6 billion in 2023 and is projected to surge to approximately USD 36.6 billion by 2033 ...
FDA researchers report that the upper end of reported consumer use (~400mg of daily CBD intake) of cannabidiol (CBD) may ...
Cannabidiol may be effective in halving the severity of symptoms and impairment caused by chronic anxiety, a pilot study by Orygen, Australia’s centre of excellence in youth mental health, has ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果